Insider Transactions in Q3 2025 at Rapport Therapeutics, Inc. (RAPP)
Insider Transaction List (Q3 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jul 15
2025
|
David Bredt Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
8,500
-1.92%
|
$119,000
$14.0 P/Share
|